<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03792685</url>
  </required_header>
  <id_info>
    <org_study_id>N N402 477437</org_study_id>
    <nct_id>NCT03792685</nct_id>
  </id_info>
  <brief_title>Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention</brief_title>
  <official_title>Analysis of Genetic Aspects of Metabolic Response on Diet With Different Content of Carbohydrate and Fat. Searching for Genetic Markers for Individualized Therapy in Patients With Obesity and Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Bialystok</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Science and Higher Education, Poland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Bialystok</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this trial are to assess the effects of interactions between genetic
      factors and diet with various macronutrient intake on the metabolic disorders, obesity and
      type 2 diabetes risk, prevention, development and progress.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, crossover study that includes 1 screening visit and four meal challenge
      test visits, separated by a 1-2-weeks washout period. The screening will include 2000 people,
      males and females, to evaluate the genotype frequencies in studied population, and to find
      carriers of the rare genetic single nucleotide polymorphisms (SNPs), who will fulfill all the
      other inclusion criteria. An oral glucose tolerance test (OGTT) will be completed at
      screening visit. Moreover, the fasting blood samples will be collected for genetic analysis,
      and measurements of blood glucose and lipid metabolism profile, high-sensitivity C-reactive
      protein (hs-CRP), hormones/peptides and other factors involved in energy balance regulation.
      Subjects will be asked to record their daily food intake for 3 days. Assessments of vital
      signs and body height and weight, waist and hip circumferences, body fat content and body fat
      distribution, review of concomitant medication/supplement use and inclusion and exclusion
      criteria, and evaluation of adverse effects will be performed throughout the study. To meal
      challenge test only men will be included, since the sex hormones may influence the study
      endpoints. Subjects will be encouraged to maintain their habitual diet during wash-out
      periods. During the each meal challenge test subjects will consume one of the study meals in
      random order. The blood will be collected at fasting state and 30, 60, 120, 180 and 240
      minutes after meal intake. The energy expenditure and substrate utilization will be measured
      by indirect calorimetry method at the fasting and postprandially.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 24, 2009</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The postprandial change and differences in blood glucose levels associated with investigated single nucleotide polymorphisms.</measure>
    <time_frame>Fasting (time 0) and 30, 60, 120, 180, 240 minutes after meal intake.</time_frame>
    <description>The postprandial change and differences in blood glucose concentrations (mg/dL) will be evaluated, dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The postprandial change and differences in serum insulin concentrations associated with investigated single nucleotide polymorphisms.</measure>
    <time_frame>Fasting (time 0) and 30, 60, 120, 180, 240 minutes after meal intake.</time_frame>
    <description>The postprandial change and differences in serum insulin concentrations (IU/mL) will be evaluated, dependently on the meal type, genetic and metabolic (body weight, body fat content)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change and differences in postprandial Triglycerides (TGs) concentrations associated with investigated single nucleotide polymorphisms.</measure>
    <time_frame>Fasting (time 0) and 30, 60, 120, 180, 240 minutes after meal intake.</time_frame>
    <description>The postprandial change and differences in blood TGs (mg/dL) concentrations will be evaluated, dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change and differences in postprandial Free Fatty Acids (FFAs) concentrations associated with investigated single nucleotide polymorphisms.</measure>
    <time_frame>Fasting (time 0) and 30, 60, 120, 180, 240 minutes after meal intake.</time_frame>
    <description>The postprandial change and differences in blood FFAs (umol/L) concentrations will be evaluated, dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change and differences in postprandial energy expenditure levels associated with investigated single nucleotide polymorphisms.</measure>
    <time_frame>Fasting (time 0) and 60, 120, 180, 240 minutes after meal intake.</time_frame>
    <description>The postprandial change and differences in energy expenditure levels (kcal/min) will be evaluated by indirect calorimetry method, dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change and differences in postprandial substrates (carbohydrate, fat and protein) utilization levels associated with investigated single nucleotide polymorphisms.</measure>
    <time_frame>Fasting (time 0) and 60, 120, 180, 240 minutes after meal intake.</time_frame>
    <description>The postprandial change and differences in substrates (carbohydrate, fat and protein) utilization (mg/min) will be evaluated by indirect calorimetry method, dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The change and differences in postprandial ghrelin concentrations associated with investigated single nucleotide polymorphisms.</measure>
    <time_frame>Fasting (time 0) and 30, 60, 120, 180, 240 minutes after meal intake.</time_frame>
    <description>The postprandial change and differences in blood ghrelin concentrations (pg/mL) will be evaluated dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change and differences in postprandial leptin concentrations associated with investigated single nucleotide polymorphisms.</measure>
    <time_frame>Fasting (time 0) and 30, 60, 120, 180, 240 minutes after meal intake.</time_frame>
    <description>The postprandial change and differences in blood leptin concentrations (ng/mL) will be evaluated dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change and differences in postprandial adiponectin concentrations associated with investigated single nucleotide polymorphisms.</measure>
    <time_frame>Fasting (time 0) and 30, 60, 120, 180, 240 minutes after meal intake.</time_frame>
    <description>The postprandial change and differences in blood adiponectin concentrations (ng/mL) will be evaluated dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change and differences in postprandial peptide YY (PYY) concentrations associated with investigated single nucleotide polymorphisms.</measure>
    <time_frame>Fasting (time 0) and 30, 60, 120, 180 minutes after meal intake.</time_frame>
    <description>The postprandial change and differences in blood PYY (pg/mL) concentrations will be evaluated dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change and differences in postprandial plasma metabolites profiles associated with investigated single nucleotide polymorphisms.</measure>
    <time_frame>Fasting (time 0) and 30, 60, 120, 180 minutes after meal intake.</time_frame>
    <description>The postprandial change and differences in plasma metabolites profiles (metabolomic fingerprinting) will be evaluated dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Overweight and Obesity</condition>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Metabolic Syndrome</condition>
  <condition>Genetic Predisposition</condition>
  <condition>Diet Modification</condition>
  <arm_group>
    <arm_group_label>Normal weight</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal weight men. Interventions: normo-carbohydrate meal intake, high-carbohydrate meal intake, high-fat meal intake, high-protein meal intake.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Overweight/obesity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Men with overweight or obesity. Interventions: normo-carbohydrate meal intake, high-carbohydrate meal intake, high-fat meal intake, high-protein meal intake.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Men with prediabetes or type 2 diabetes mellitus. Interventions: normo-carbohydrate meal intake, high-carbohydrate meal intake, high-fat meal intake, high-protein meal intake.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normo-carbohydrate meal intake</intervention_name>
    <description>Subjects are going to receive the normo-carbohydrate meal.</description>
    <arm_group_label>Diabetes</arm_group_label>
    <arm_group_label>Normal weight</arm_group_label>
    <arm_group_label>Overweight/obesity</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High-carbohydrate meal intake</intervention_name>
    <description>Subjects are going to receive the high-carbohydrate meal.</description>
    <arm_group_label>Diabetes</arm_group_label>
    <arm_group_label>Normal weight</arm_group_label>
    <arm_group_label>Overweight/obesity</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High-fat meal intake</intervention_name>
    <description>Subjects are going to receive the high-fat meal.</description>
    <arm_group_label>Diabetes</arm_group_label>
    <arm_group_label>Normal weight</arm_group_label>
    <arm_group_label>Overweight/obesity</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High-protein meal intake</intervention_name>
    <description>Subjects are going to receive the high-protein meal.</description>
    <arm_group_label>Diabetes</arm_group_label>
    <arm_group_label>Normal weight</arm_group_label>
    <arm_group_label>Overweight/obesity</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy men with normal body weight and with overweight/obesity

          -  men with metabolic syndrome, hypertension, type 2 diabetes newly diagnosed, or not
             treated with any medicines

          -  maintaining the usual diet and lifestyle throughout the study

        Exclusion Criteria:

          -  infectious or acute diseases in the last 4 weeks before the study visits

          -  any medicines/dietary supplements consumption in the last 4 weeks before the study
             visits

          -  high level of daily physical activity

          -  the following any special diet or dietary patterns (vegetarian, high-fat etc.)

          -  the presence of any other significant disease which may affect the results (hormonal
             disorders, history of any surgeries on gastrointestinal tract, allergies known or
             suspected, heart failure, history of cancer, any kidney, pancrea and liver diseases,
             except non-alcoholic fatty liver)

          -  abusive alcohol consumption

          -  abusive coffee or energy drinks consumption

          -  drug consumption
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edyta Adamska-Patruno, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Clinical Research Centre, Medical University of Bialystok</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Gorska, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept of Endocrinology, Diabetology and Internal Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adam Kretowski, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept of Endocrinology, Diabetology and Internal Medicine; Clinical Research Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Edyta Adamska-Patruno, PhD</last_name>
    <phone>+48693726228</phone>
    <email>edyta.adamska@wp.pl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinical Research Centre, Medical University of Bialystok</name>
      <address>
        <city>Bialystok</city>
        <state>Polska</state>
        <zip>15-276</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edyta Adamska-Patruno, PhD</last_name>
      <phone>+48693726228</phone>
      <email>edyta.adamska@wp.pl</email>
    </contact>
    <investigator>
      <last_name>Maria Gorska, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adam Kretowski, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edyta Adamska-Patruno, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <results_reference>
    <citation>Adamska E, Ostrowska L, Gościk J, Waszczeniuk M, Krętowski A, Górska M. Intake of Meals Containing High Levels of Carbohydrates or High Levels of Unsaturated Fatty Acids Induces Postprandial Dysmetabolism in Young Overweight/Obese Men. Biomed Res Int. 2015;2015:147196. doi: 10.1155/2015/147196. Epub 2015 Nov 2.</citation>
    <PMID>26609520</PMID>
  </results_reference>
  <results_reference>
    <citation>Ciborowski M, Adamska E, Rusak M, Godzien J, Wilk J, Citko A, Bauer W, Gorska M, Kretowski A. CE-MS-based serum fingerprinting to track evolution of type 2 diabetes mellitus. Electrophoresis. 2015 Sep;36(18):2286-2293. doi: 10.1002/elps.201500021. Epub 2015 Jun 26.</citation>
    <PMID>25964024</PMID>
  </results_reference>
  <results_reference>
    <citation>Kretowski A, Adamska E, Maliszewska K, Wawrusiewicz-Kurylonek N, Citko A, Goscik J, Bauer W, Wilk J, Golonko A, Waszczeniuk M, Lipinska D, Hryniewicka J, Niemira M, Paczkowska M, Ciborowski M, Gorska M. The rs340874 PROX1 type 2 diabetes mellitus risk variant is associated with visceral fat accumulation and alterations in postprandial glucose and lipid metabolism. Genes Nutr. 2015 Mar;10(2):4. doi: 10.1007/s12263-015-0454-6. Epub 2015 Jan 20.</citation>
    <PMID>25601634</PMID>
  </results_reference>
  <results_reference>
    <citation>Ostrowska L, Fiedorczuk J, Adamska E. Effect of diet and other factors on serum adiponectin concentrations in patients with type 2 diabetes. Rocz Panstw Zakl Hig. 2013;64(1):61-6.</citation>
    <PMID>23789315</PMID>
  </results_reference>
  <results_reference>
    <citation>Ostrowska L, Witczak K, Adamska E. Effect of nutrition and atherogenic index on the occurrence and intensity of insulin resistance. Pol Arch Med Wewn. 2013;123(6):289-96. Epub 2013 Jun 5.</citation>
    <PMID>23739212</PMID>
  </results_reference>
  <results_reference>
    <citation>Adamska E, Ostrowska L, Adamska E, Maliszewska K, Citko A, Waszczeniuk M, Przystupa W, Majewski R, Wasilewska A, Milewski R, Krytowski A, Górska M. [Differences in dietary habits and food preferences of adults depending on the age]. Rocz Panstw Zakl Hig. 2012;63(1):73-81. Polish.</citation>
    <PMID>22642073</PMID>
  </results_reference>
  <results_reference>
    <citation>Adamska E, Waszczeniuk M, Gościk J, Golonko A, Wilk J, Pliszka J, Maliszewska K, Lipińska D, Milewski R, Wasilewska A, Citko A, Nikołajuk A, Ostrowska L, Krętowski A, Górska M. The usefulness of glycated hemoglobin A1c (HbA1c) for identifying dysglycemic states in individuals without previously diagnosed diabetes. Adv Med Sci. 2012;57(2):296-301.</citation>
    <PMID>22968341</PMID>
  </results_reference>
  <results_reference>
    <citation>Adamska-Patruno E, Ostrowska L, Golonko A, Pietraszewska B, Goscik J, Kretowski A, Gorska M. Evaluation of Energy Expenditure and Oxidation of Energy Substrates in Adult Males after Intake of Meals with Varying Fat and Carbohydrate Content. Nutrients. 2018 May 16;10(5). pii: E627. doi: 10.3390/nu10050627.</citation>
    <PMID>29772667</PMID>
  </results_reference>
  <results_reference>
    <citation>Adamska E, Kretowski A, Goscik J, Citko A, Bauer W, Waszczeniuk M, Maliszewska K, Paczkowska-Abdulsalam M, Niemira M, Szczerbinski L, Ciborowski M, Gorska M. The type 2 diabetes susceptibility TCF7L2 gene variants affect postprandial glucose and fat utilization in non-diabetic subjects. Diabetes Metab. 2018 Sep;44(4):379-382. doi: 10.1016/j.diabet.2017.05.001. Epub 2017 May 31.</citation>
    <PMID>28579156</PMID>
  </results_reference>
  <results_reference>
    <citation>Adamska-Patruno E, Ostrowska L, Goscik J, Pietraszewska B, Kretowski A, Gorska M. The relationship between the leptin/ghrelin ratio and meals with various macronutrient contents in men with different nutritional status: a randomized crossover study. Nutr J. 2018 Dec 28;17(1):118. doi: 10.1186/s12937-018-0427-x.</citation>
    <PMID>30593267</PMID>
  </results_reference>
  <results_reference>
    <citation>Adamska-Patruno E, Goscik J, Czajkowski P, Maliszewska K, Ciborowski M, Golonko A, Wawrusiewicz-Kurylonek N, Citko A, Waszczeniuk M, Kretowski A, Gorska M. The MC4R genetic variants are associated with lower visceral fat accumulation and higher postprandial relative increase in carbohydrate utilization in humans. Eur J Nutr. 2019 Oct;58(7):2929-2941. doi: 10.1007/s00394-019-01955-0. Epub 2019 Apr 3.</citation>
    <PMID>30945034</PMID>
  </results_reference>
  <results_reference>
    <citation>Godzien J, Kalaska B, Adamska-Patruno E, Siroka J, Ciborowski M, Kretowski A, Barbas C. Oxidized glycerophosphatidylcholines in diabetes through non-targeted metabolomics: Their annotation and biological meaning. J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jul 1;1120:62-70. doi: 10.1016/j.jchromb.2019.04.053. Epub 2019 Apr 29.</citation>
    <PMID>31071580</PMID>
  </results_reference>
  <results_reference>
    <citation>Szczerbiński Ł, Gościk J, Bauer W, Wawrusiewicz-Kurylonek N, Paczkowska-Abdulsalam M, Niemira M, Citko A, Adamska-Patruno E, Górska M, Krętowski A. Efficacy of family history, genetic risk score, and physical activity in assessing the prevalence of type 2 diabetes. Pol Arch Intern Med. 2019 Aug 29;129(7-8):442-450. doi: 10.20452/pamw.14866. Epub 2019 Jun 6.</citation>
    <PMID>31169260</PMID>
  </results_reference>
  <results_reference>
    <citation>Adamska-Patruno E, Samczuk P, Ciborowski M, Godzien J, Pietrowska K, Bauer W, Gorska M, Barbas C, Kretowski A. Metabolomics Reveal Altered Postprandial Lipid Metabolism After a High-Carbohydrate Meal in Men at High Genetic Risk of Diabetes. J Nutr. 2019 Jun 1;149(6):915-922. doi: 10.1093/jn/nxz024.</citation>
    <PMID>31049566</PMID>
  </results_reference>
  <results_reference>
    <citation>Adamska-Patruno E, Godzien J, Ciborowski M, Samczuk P, Bauer W, Siewko K, Gorska M, Barbas C, Kretowski A. The Type 2 Diabetes Susceptibility PROX1 Gene Variants Are Associated with Postprandial Plasma Metabolites Profile in Non-Diabetic Men. Nutrients. 2019 Apr 19;11(4). pii: E882. doi: 10.3390/nu11040882.</citation>
    <PMID>31010169</PMID>
  </results_reference>
  <results_reference>
    <citation>Maliszewska K, Adamska-Patruno E, Goscik J, Lipinska D, Citko A, Krahel A, Miniewska K, Fiedorczuk J, Moroz M, Gorska M, Kretowski A. The Role of Muscle Decline in Type 2 Diabetes Development: A 5-Year Prospective Observational Cohort Study. Nutrients. 2019 Apr 12;11(4). pii: E834. doi: 10.3390/nu11040834.</citation>
    <PMID>31013777</PMID>
  </results_reference>
  <results_reference>
    <citation>Adamska-Patruno E, Ostrowska L, Goscik J, Fiedorczuk J, Moroz M, Kretowski A, Gorska M. The Differences in Postprandial Serum Concentrations of Peptides That Regulate Satiety/Hunger and Metabolism after Various Meal Intake, in Men with Normal vs. Excessive BMI. Nutrients. 2019 Feb 26;11(3). pii: E493. doi: 10.3390/nu11030493.</citation>
    <PMID>30813625</PMID>
  </results_reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 26, 2018</study_first_submitted>
  <study_first_submitted_qc>January 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 3, 2019</study_first_posted>
  <last_update_submitted>January 14, 2020</last_update_submitted>
  <last_update_submitted_qc>January 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

